Fresenius to focus on growth from 2020

Stephan Sturm, chief executive of Fresenius

Fresenius has said that 2019 will be a year of investment after a challenging year that saw cost pressures outpace revenue growth for the German healthcare group. “2018 was not an easy year, and yet it was another successful one for Fresenius. We have further developed and enhanced our medical offering, while once again increasing…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »